Description: Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company provides mono methyl and die methyl urea, ortho para nitro anisole, 2 bromomethyl 1, and 3 dioxalane and uracile, as well as active pharma ingredients, such as metformin HCL, mefenamic acid, and doxophylline. It also offers chemicals and solvents, including aromatic chemicals, chemical acids, chlor alkalies, glycols and glycol ethers, fiber intermediates, acetates and esters, and chlorinated solvents, as well as industrial alchols, ketones, amines, oleochemicals, intermediates, olefines, phosphates, fertilizers, monomers, and chemicals. In addition, the company trades in industrial solvents and chemicals.The company's pharmaceutical products are used by pharmaceutical formulation manufacturers and pharmaceutical merchant exporters. Aarey Drugs & Pharmaceuticals Limited was incorporated in 1990 and is headquartered in Mumbai, India.
Home Page: www.aareydrugs.com
107, Sahakar Bhavan
Mumbai,
400009
India
Phone:
91 22 6287 2900
Officers
| Name | Title |
|---|---|
| Mr. Mihir Rajesh Ghatalia B.E | Chairman & MD |
| Mr. Nimit Rajesh Ghatalia | Executive Director |
| Ms. Mira Mihir Ghatalia | Chief Financial Officer |
| Mr. A. S. Kathawala | Chief Accountant |
| Ms. Preeti Paresh Rathi | Company Secretary & Compliance Officer |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 27.4336 |
| Price-to-Book MRQ: | 1.2965 |
| Price-to-Sales TTM: | 0.3728 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 0 |